Announcement of The Consolidated Financial Report for The 1st Quarter of 2022
2022.5.13
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/05/13 | Time of announcement | 17:55:48 |
| Subject | Announcement of The Consolidated Financial Report for The 1st Quarter of 2022 | ||||
| Date of events | 2022/05/13 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2022/05/13 2.Date of the financial reports approved by the audit committee:2022/05/13 3.Start and end dates of financial reports of the reporting period:2022/01/01~2022/03/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):1,037,114 5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):646,988 6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):246,556 7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):287,247 8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):227,941 9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):227,507 10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):0.91 11.Total assets end of the period (thousand NTD):9,269,538 12.Total liabilities end of the period (thousand NTD):3,220,092 13.Equity attributable to owners of parent end of the period (thousand NTD):5,452,702 14.Any other matters that need to be specified:None |
||||